QurCan Therapeutics (AKA Nanology Labs) Secures $3 Million in Oversubscribed Seed Round

May 11, 2021

QurCan Therapeutics, an IND-stage company developing next generation nanomedicines announced today that its seed capital raise was oversubscribed at $3M.

The round was led by FACIT with co-investors Creative Destruction Lab Angels, Ontario Brain Institute, Ontario Center of Innovation, and MEDTEQ.

Source: https://www.businesswire.com/news/home/20210517005067/en/Nanology-Labs-Secures-%243-Million-in-Oversubscribed-Seed-Round